GENDAI AGENCY INC. Logo

GENDAI AGENCY INC.

Advertising agency providing marketing and promotions for the pachinko industry.

2411 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
新宿区西新宿三丁目20番2号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

GENDAI AGENCY INC. is an advertising company that specializes in providing marketing and promotional services to the pachinko industry. The company supports the marketing strategies of pachinko parlors through the planning and production of various advertisements and promotions. Describing itself as an "earnings growth support team," its stated mission is to enhance the earnings and support the growth of its clients' businesses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-01 06:28
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.7 KB
2025-08-01 07:30
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.1 KB
2025-07-01 05:47
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.6 KB
2025-06-26 02:45
Regulatory News Service
臨時報告書
Japanese 21.9 KB
2025-06-24 03:01
Registration Form
確認書
Japanese 8.2 KB
2025-06-24 02:59
Governance Information
内部統制報告書-第30期(2024/04/01-2025/03/31)
Japanese 25.2 KB
2025-06-24 02:55
Annual Report
有価証券報告書-第30期(2024/04/01-2025/03/31)
Japanese 797.3 KB
2025-06-02 08:20
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.7 KB
2025-05-01 05:41
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.5 KB
2025-04-21 02:04
Regulatory News Service
臨時報告書
Japanese 18.5 KB
2024-10-31 01:41
Report Publication Announcement
確認書
Japanese 8.2 KB
2024-10-31 01:40
Interim Report
半期報告書-第30期(2024/04/01-2025/03/31)
Japanese 180.3 KB
2024-06-24 08:24
Post-Annual General Meeting Information
訂正臨時報告書
Japanese 29.2 KB
2024-06-24 03:51
Regulatory News Service
臨時報告書
Japanese 22.0 KB
2024-06-24 02:43
Regulatory News Service
確認書
Japanese 8.2 KB

Automate Your Workflow. Get a real-time feed of all GENDAI AGENCY INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GENDAI AGENCY INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea 187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea 048410
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea 456570
Immunic AG Logo
Developing oral therapies for autoimmune diseases like multiple sclerosis and celiac disease.
United States of America IMUX
Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.
Japan 6535
INBIOGEN CO.,Ltd Logo
Data mining, bioinformatics, and virtual assistance for the life sciences industry.
South Korea 101140
Incross Co.,Ltd. Logo
A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.
South Korea 216050
INEST,Inc. Logo
Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.
Japan 7111
Innate Pharma Logo
Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.
France IPH
Innovation Inc. Logo
Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.
Japan 3970

Talk to a Data Expert

Have a question? We'll get back to you promptly.